|
FR2470599A1
(fr)
*
|
1979-12-07 |
1981-06-12 |
Panoz Donald |
Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
|
|
DE3237575A1
(de)
*
|
1982-10-09 |
1984-04-12 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue orale mopidamolformen
|
|
HU191542B
(en)
*
|
1983-04-08 |
1987-03-30 |
Boehringer Ingelheim Ltd |
Process for production of pastiles containing dipyridamel independent from ph with regulated output of the active substance
|
|
DE3314003A1
(de)
*
|
1983-04-18 |
1984-10-18 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
|
|
DE3320582A1
(de)
*
|
1983-06-08 |
1984-12-13 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
|
|
DE3320583A1
(de)
*
|
1983-06-08 |
1984-12-13 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
|
|
JPS6051106A
(ja)
*
|
1983-08-31 |
1985-03-22 |
Yamanouchi Pharmaceut Co Ltd |
塩酸アモスラロ−ル持続性製剤
|
|
US4867984A
(en)
*
|
1984-11-06 |
1989-09-19 |
Nagin K. Patel |
Drug in bead form and process for preparing same
|
|
CA1323833C
(en)
*
|
1987-04-28 |
1993-11-02 |
Yatindra M. Joshi |
Pharmaceutical compositions in the form of beadlets and method
|
|
GB8813032D0
(en)
*
|
1988-06-02 |
1988-07-06 |
Boehringer Ingelheim Int |
Antiviral pharmaceutical composition
|
|
US5064656A
(en)
*
|
1989-11-14 |
1991-11-12 |
Dr. Gergely & Co. |
Uncoated pharmaceutical reaction tablet
|
|
JPH0674206B2
(ja)
*
|
1989-12-28 |
1994-09-21 |
田辺製薬株式会社 |
放出制御型製剤およびその製法
|
|
US5364646A
(en)
*
|
1990-01-10 |
1994-11-15 |
Dr. Karl Thomae Gmbh |
Oral pharmaceutical forms of pimobendan
|
|
HU222489B1
(hu)
*
|
1990-07-25 |
2003-07-28 |
Novartis Ag. |
Stabilizált gyógyszerkészítmények és eljárás az előállításukra
|
|
US6300361B1
(en)
|
1990-07-25 |
2001-10-09 |
Novartis Ag |
Stabilized pharmaceutical compositions comprising acid donors
|
|
ATE120089T1
(de)
*
|
1991-05-20 |
1995-04-15 |
Marion Laboratories Inc |
Mehrschichtige zubereitung mit kontrollierter freisetzung.
|
|
US5302393A
(en)
*
|
1991-07-11 |
1994-04-12 |
Kanegafuchi Kagaku Kogyo Kabushiki Kaisha |
Method for inhibiting biological degradation of implantation polymeric material, inhibitor thereof and implantation polymeric material containing the inhibitor
|
|
US5270047A
(en)
*
|
1991-11-21 |
1993-12-14 |
Kauffman Raymond F |
Local delivery of dipyridamole for the treatment of proliferative diseases
|
|
DE19845358A1
(de)
*
|
1998-10-02 |
2000-04-06 |
Roehm Gmbh |
Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
|
|
EP1093814A1
(en)
*
|
1999-10-22 |
2001-04-25 |
Boehringer Ingelheim Pharma KG |
Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
|
|
US7064130B2
(en)
*
|
2001-04-20 |
2006-06-20 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
|
|
DE10149674A1
(de)
|
2001-10-09 |
2003-04-24 |
Apogepha Arzneimittel Gmbh |
Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
|
|
JP4331930B2
(ja)
*
|
2001-10-17 |
2009-09-16 |
武田薬品工業株式会社 |
酸に不安定な薬物の高含量顆粒
|
|
US20030181488A1
(en)
*
|
2002-03-07 |
2003-09-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
|
|
WO2004069254A2
(en)
*
|
2003-02-07 |
2004-08-19 |
Boehringer Ingelheim International Gmbh |
Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders
|
|
DE10306179A1
(de)
|
2003-02-13 |
2004-08-26 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
|
|
JP2006524203A
(ja)
|
2003-04-24 |
2006-10-26 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
トロンビンの過剰形成及び／又はトロンビンレセプターの発現上昇により生じる血栓塞栓性疾病及び疾患の治療及び予防のためのジピリダモール又はモピダモールの使用
|
|
DE10339862A1
(de)
*
|
2003-08-29 |
2005-03-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
|
|
EP1579862A1
(en)
|
2004-03-25 |
2005-09-28 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
|
|
US8980894B2
(en)
|
2004-03-25 |
2015-03-17 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
|
|
RU2006143838A
(ru)
*
|
2004-05-13 |
2008-06-20 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
Применение дипиридамола для лечения устойчивости к ингибиторам тромбоцитов
|
|
BG860Y1
(bg)
*
|
2004-09-17 |
2007-02-28 |
"Софарма" Ад |
Лекарствена форма на дипиридамол
|
|
EP2559430B1
(en)
|
2005-03-22 |
2015-06-24 |
Losan Pharma GmbH |
Solubilized Ibuprofen
|
|
US20070087056A1
(en)
*
|
2005-08-09 |
2007-04-19 |
Claudia Guthmann |
Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
|
|
GB0517204D0
(en)
*
|
2005-08-22 |
2005-09-28 |
Novartis Ag |
Organic compounds
|
|
JP2009504796A
(ja)
*
|
2005-08-22 |
2009-02-05 |
ノバルティス アクチエンゲゼルシャフト |
ｐＨ依存性薬剤化合物、ｐＨ調整剤および遅延剤を含む医薬組成物
|
|
EP1976491B1
(en)
*
|
2006-01-27 |
2014-12-17 |
Aptalis Pharmatech, Inc. |
Drug delivery systems comprising weakly basic selective serotonin 5-ht3 blocking agent and organic acids
|
|
KR101489401B1
(ko)
*
|
2006-01-27 |
2015-02-03 |
앱탈리스 파마테크, 인코포레이티드 |
약 염기성 약물과 유기산을 포함하는 약물 전달 시스템
|
|
EP1820506B1
(en)
*
|
2006-02-09 |
2008-03-26 |
Teva Pharmaceutical Industries Ltd. |
Dipyridamole extended-release formulations and process for preparing same
|
|
EP1920785A1
(en)
|
2006-11-07 |
2008-05-14 |
Boehringer Ingelheim Vetmedica Gmbh |
Liquid preparation comprising a complex of pimobendan and cyclodextrin
|
|
CN101910113A
(zh)
|
2007-12-28 |
2010-12-08 |
怡百克制药公司 |
左旋多巴控释制剂及其用途
|
|
US20090196935A1
(en)
*
|
2008-02-01 |
2009-08-06 |
Ahmed Salah U |
Pharmaceutical Capsules Comprising Extended Release Dipyridamole Pellets
|
|
US8133506B2
(en)
*
|
2008-03-12 |
2012-03-13 |
Aptalis Pharmatech, Inc. |
Drug delivery systems comprising weakly basic drugs and organic acids
|
|
US20100080846A1
(en)
*
|
2008-09-25 |
2010-04-01 |
Avshalom Ben-Menachem |
Dipyridamole and acetylsalicylic acid formulations and process for preparing same
|
|
US20110003005A1
(en)
*
|
2009-07-06 |
2011-01-06 |
Gopi Venkatesh |
Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
|
|
WO2011014741A1
(en)
*
|
2009-07-31 |
2011-02-03 |
Artemis Health, Inc. |
Methods and compositions for cell stabilization
|
|
EP2361615A1
(en)
|
2010-02-19 |
2011-08-31 |
Alfred E. Tiefenbacher GmbH & Co. KG |
Dipyridamole prolonged-release tablet
|
|
WO2012162492A1
(en)
*
|
2011-05-24 |
2012-11-29 |
Teva Pharmaceutical Industries Ltd. |
Compressed core comprising organic acids for a pharmaceutical composition
|
|
EP2825159B1
(en)
|
2012-03-15 |
2022-06-22 |
Boehringer Ingelheim Vetmedica GmbH |
Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
|
|
CN113181110A
(zh)
|
2013-07-19 |
2021-07-30 |
勃林格殷格翰动物保健有限公司 |
含有防腐的醚化的环糊精衍生物的液体水性药物组合物
|
|
US10987313B2
(en)
|
2013-10-07 |
2021-04-27 |
Impax Laboratories, Llc |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
EP3782614A1
(en)
|
2013-10-07 |
2021-02-24 |
Impax Laboratories, LLC |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
EA034054B1
(ru)
|
2013-12-04 |
2019-12-23 |
Бёрингер Ингельхайм Ветмедика Гмбх |
Улучшенные фармацевтические композиции пимобендана
|
|
US10537570B2
(en)
|
2016-04-06 |
2020-01-21 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
|
|
US12194150B2
(en)
|
2020-12-22 |
2025-01-14 |
Amneal Pharmaceuticals Llc |
Levodopa dosing regimen
|
|
US11986449B2
(en)
|
2020-12-22 |
2024-05-21 |
Amneal Pharmaceuticals Llc |
Levodopa dosing regimen
|